A SAR study on a series of synthetic lipophilic chalcones as Inhibitor of transcription factor NF-κB

被引:9
|
作者
Venkateswararao, Eeda [1 ,2 ]
Sharma, Vinay K. [1 ,2 ]
Lee, Ki-Cheul [1 ,2 ]
Sharma, Niti [1 ,2 ]
Park, Sun-Hong [3 ]
Kim, Youngsoo [3 ]
Jung, Sang-Hun [1 ,2 ]
机构
[1] Natl Univ, Coll Pharm, Taejon 305764, South Korea
[2] Natl Univ, Inst Drug Res & Dev, Taejon 305764, South Korea
[3] Chungbuk Natl Univ, Coll Pharm, Cheongju 361763, South Korea
基金
新加坡国家研究基金会;
关键词
Chalcones; LPS induced NF-kappa B inhibition; Inflammation; Sepsis; ACTIVATED PROTEIN-C; LIPID-A; CYTOKINE PRODUCTION; SEPTIC SHOCK; ENDOTOXIN; LIPOPOLYSACCHARIDE; SEQUESTRATION; DISCOVERY; POLYMYXIN; BINDING;
D O I
10.1016/j.ejmech.2012.05.019
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
To define the structural features responsible for the activity of 2,4-dihydroxy-6-isopentyloxychalcone, a newly established inhibitor of LPS induced NF-kappa B activation (IC50 = 10 mu M), a series of its analogues was prepared and studied for their in vitro activities against LPS induced NF-kappa B inhibition in RAW 264.7 cells. Among the synthesized derivatives, (E)-1-(2-(decyloxy)-6-hydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one (1050 = 2.7 mu M) and (E)-1-(2-hydroxy-6-(tetradecyloxy)phenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one (IC50 = 4.2 mu M) showed the most potent inhibition. The SAR studies confirmed that the length (C-8-C-14) and C-6 position of linear alkyl chain of ring A is an important factor for the inhibitory activity. Hydroxyl group and its location at 4-position on ring B is also important for the inhibition. The alpha,beta-unsaturated ketone moiety appears as a crucial motif of chalcones for the activity. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:379 / 386
页数:8
相关论文
共 50 条
  • [1] Synthetic oligonucleotides as inhibitors of the NF-κB transcription factor
    Kozlov, IA
    Kubareva, EA
    Shabarova, ZA
    MOLECULAR BIOLOGY, 1998, 32 (03) : 315 - 325
  • [2] Exploration of SAR for novel 2-benzylbenzimidazole analogs as inhibitor of transcription factor NF-κB
    PullaReddy Boggu
    Eeda Venkateswararao
    Manoj Manickam
    Youngsoo Kim
    Sang-Hun Jung
    Archives of Pharmacal Research, 2017, 40 : 469 - 479
  • [3] Exploration of SAR for novel 2-benzylbenzimidazole analogs as inhibitor of transcription factor NF-κB
    Boggu, PullaReddy
    Venkateswararao, Eeda
    Manickam, Manoj
    Kim, Youngsoo
    Jung, Sang-Hun
    ARCHIVES OF PHARMACAL RESEARCH, 2017, 40 (04) : 469 - 479
  • [4] Regulation of activity of transcription factor NF-κB by synthetic oligonucleotides
    V. G. Metelev
    E. A. Kubareva
    T. S. Oretskaya
    Biochemistry (Moscow), 2013, 78 : 867 - 878
  • [5] Regulation of activity of transcription factor NF-κB by synthetic oligonucleotides
    Metelev, V. G.
    Kubareva, E. A.
    Oretskaya, T. S.
    BIOCHEMISTRY-MOSCOW, 2013, 78 (08) : 867 - 878
  • [6] Synthetic access to potential modulators of the transcription factor NF-κB
    DePorre, Yvonne C.
    Schindler, Corinna S.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [7] Effect of a synthetic lipid immunomodulator on the regulation of the transcription factor NF-κB
    Pollet, S
    Bottex-Gauthier, C
    Picot, F
    Potier, P
    Vidal, D
    Favier, A
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2000, 22 (04) : 653 - 669
  • [8] Synthetic strategy to access potential modulators of the transcription factor NF-κB
    Armaly, Ahlam
    Bar, Sukanta
    Schindler, Corinna
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [9] A Novel Quinoline Inhibitor of the Canonical NF-κB Transcription Factor Pathway
    Ntavaroukas, Panagiotis
    Michail, Konstantinos
    Tsiakalidou, Rafaela
    Stampouloglou, Eleni
    Tsiggene, Katerina
    Komiotis, Dimitrios
    Georgiou, Nikitas
    Mavromoustakos, Thomas
    Manta, Stella
    Aje, Danielle
    Michael, Panagiotis
    Campbell, Barry J.
    Papoutsopoulou, Stamatia
    BIOLOGY-BASEL, 2024, 13 (11):
  • [10] Transcription factor NF-κB in glomerulonephritis
    Auwardt, RB
    Mudge, SJ
    Power, DA
    NEPHROLOGY, 2000, 5 (1-2) : 71 - 82